Evidence map›Paper›PMID 35841024›Full record

ArticleBMC public health2022

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].

Brett M Goshe, Autumn W Rasmussen, Lynne I Wagner, JoRean D Sicks, Ilana F Gareen, Ruth C Carlos, Benjamin A Herman, Angela Wangari Walter, Susan Regan, Douglas E Levy and 12 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03808818 (Implementing a Virtual Tobacco Treatment in Community Oncology Practices), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03808818 nacompletednot on this map

Implementing a Virtual Tobacco Treatment in Community Oncology Practices: "Smoke Free Support Study 2.0"

TypeinterventionalSponsorECOG-ACRIN Cancer Research GroupRan2019 to 2023Enrolled306ConditionsCarcinoma In Situ, Current Smoker, Malignant Neoplasm, Primary NeoplasmArmsBehavioral, Psychological or Informational Intervention, Nicotine Replacement, Quality-of-Life Assessment, Survey Administration, Tobacco Cessation Counseling
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD).Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

Brett M GosheDepartment of Psychiatry, Massachusetts General Hospital / Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA. bgoshe@mgh.harvard.edu.
Autumn W RasmussenDepartment of Psychiatry, Massachusetts General Hospital / Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Lynne I WagnerWake Forest University School of Medicine, Winston-Salem, NC, USA.
JoRean D SicksECOG-ACRIN Biostatistics Center, Brown University, Providence, RI, USA.
Ilana F GareenDepartment of Epidemiology and the Center for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
Ruth C CarlosMichigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Benjamin A HermanECOG-ACRIN Biostatistics Center, Brown University, Providence, RI, USA.
Angela Wangari WalterHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Susan ReganMongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA, USA.
Douglas E LevyMongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA, USA.
Irene MahonECOG-ACRIN Cancer Research Group, American College of Radiology, Philadelphia, PA, USA.
Alona MuzikanskyBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Jordan M NeilHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Michelle LuiDepartment of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deepika DilipDepartment of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Laura MalloyHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Irina GonzalezHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Lucy Finkelstein-FoxDepartment of Psychiatry, Massachusetts General Hospital / Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Caitlin McCannHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Elissa PerezHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Jamie S Ostroff *Health Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Elyse R Park *Department of Psychiatry, Massachusetts General Hospital / Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Massachusetts General Hospital · USBrown University · USHarvard University · USMemorial Sloan Kettering Cancer Center · USAmerican College of Radiology · USMichigan Medicine · USUniversity of Massachusetts Lowell · USWake Forest University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
Psychosocial Palliative & Community Research in CancerT32CA009461 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JENNIFER L HAY, Jamie S. Ostroff · 1985 to 2026
$10.1M
Organizational readiness and engagement of community oncology practices in implementing tobacco use assessment and treatmentR01CA214427 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI OSTROFF, JAMIE S., PARK, ELYSE R. · 2018 to 2023
$3.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA214427NCI NIH HHS T32 CA009461NCI NIH HHS UG1 CA189828
6 · The paper itself

Abstract

backgroundPersistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet an evidence-based tobacco use intervention has not been well-integrated into cancer care in community oncology settings. This paper describes the protocol of a nation-wide clinical trial conducted by the ECOG-ACRIN National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base to assess the effectiveness of a virtual tobacco treatment intervention and the process of implementing tobacco treatment in NCORP community oncology settings. METHODS/

designThis two-arm, multisite (n: 49 NCORP sites) hybrid type 1 effectiveness-implementation randomized controlled trial compares the effectiveness of a Virtual Intervention Treatment (VIT) versus an Enhanced Usual Control (EUC) among English and Spanish speaking patients recently diagnosed with cancer, reporting current smoking and receiving care at a participating NCORP Community or Minority/Underserved Site. The VIT includes up to 11 virtual counseling sessions with a tobacco treatment specialist and up to 12 weeks of nicotine replacement therapy (NRT). The EUC arm receives a referral to the NCI Quitline. The primary study outcome is biochemically confirmed 7-day point prevalence smoking abstinence. Moderators of treatment effect will be assessed. The study evaluates implementation processes from participating NCORP site staff via survey, administrative, and focus group data, including reach, acceptability, appropriateness, fidelity, feasibility, adoption, cost and sustainability outcomes. DISCUSSION: This trial will generate findings about the effectiveness of an evidence-based virtual tobacco treatment intervention targeting patients diagnosed with cancer and illuminate barriers and facilitators that influence implementing tobacco treatment into community oncology settings nationally. In the era of COVID-19, virtual care solutions are vital for maximizing access and utilization of tobacco treatment delivery.

trial registrationClinicalTrials.gov (NCT03808818) on January 18th, 2019; Last update posted: May 21st, 2020.

Indexed as

TelemedicineTobacco UseCounselingCOVID-19HumansMulticenter Studies as TopicNeoplasmsRandomized Controlled Trials as TopicSmoking CessationTreatment OutcomeCancer CareImplementing Tobacco TreatmentMotivational InterviewingNCORPPharmacotherapyRandomized Controlled TrialSmoking CessationTobacco Treatment

Identifiers

PMID35841024
PMCPMC9284951
OpenAlexW4285591285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.